A high-throughput strategy for COVID-19 testing based on next-generation sequencing
View ORCID ProfileJian Huang, Lan Zhao
doi: https://doi.org/10.1101/2020.06.12.20129718
Jian Huang
Department of Orthopedic Surgery, Rush University Medical Center, Chicago, IL 60612, USA
Lan Zhao
Department of Orthopedic Surgery, Rush University Medical Center, Chicago, IL 60612, USA
Article usage
Posted June 19, 2020.
A high-throughput strategy for COVID-19 testing based on next-generation sequencing
Jian Huang, Lan Zhao
medRxiv 2020.06.12.20129718; doi: https://doi.org/10.1101/2020.06.12.20129718
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2257)
- Dermatology (201)
- Emergency Medicine (368)
- Epidemiology (11549)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3541)
- Geriatric Medicine (336)
- Health Economics (612)
- Health Informatics (2287)
- Health Policy (910)
- Hematology (333)
- HIV/AIDS (742)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3326)
- Nursing (190)
- Nutrition (504)
- Oncology (1748)
- Ophthalmology (522)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (222)
- Palliative Medicine (66)
- Pathology (435)
- Pediatrics (998)
- Primary Care Research (399)
- Public and Global Health (5974)
- Radiology and Imaging (1216)
- Respiratory Medicine (807)
- Rheumatology (367)
- Sports Medicine (311)
- Surgery (383)
- Toxicology (50)
- Transplantation (170)
- Urology (142)